Ultrasound stimulation restores impaired neovascularization-related capacities of human circulating angiogenic cells

Cardiovascular Research

Volumn 95, Issue 4, 2012, Pages 448-459

  Toyama, Yasuyuki ^a   Sasaki, Ken Ichiro ^a   Tachibana, Katsuro ^b   Ueno, Takafumi ^a   Kajimoto, Hidemi ^c   Yokoyama, Shinji ^a   Ohtsuka, Masanori ^a   Koiwaya, Hiroshi ^a   Nakayoshi, Takaharu ^a   Mitsutake, Yoshiaki ^a   Chibana, Hidetoshi ^a   Itaya, Naoki ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

Atherosclerotic risk factors; Cell therapy; Circulating angiogenic cells; Neovascularization; Ultrasound pre treatment

Indexed keywords

ANGIOPOIETIN 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; PROTEIN KINASE B;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; HINDLIMB; HUMAN; HUMAN CELL; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ULTRASOUND; WESTERN BLOTTING;

ANGIOPOIETIN-2; ANIMALS; ATHEROSCLEROSIS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HINDLIMB; HUMANS; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, NUDE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS; ULTRASONICS; UP-REGULATION;

EID: 84865275800     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs173     Document Type: Article

References (43)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6: 389-395.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
3. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, Duan J et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001;103:897-903.
4. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004;109:2692-2697.
5. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda S et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 2006; 98:1194-1202.
6. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-435.
7. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 2008;156:1010-1018.
8. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1-E7.
9. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008;102:1319-1330.
10. Miura S, Tachibana K, Okamoto T, Saku K. In vitro transfer of antisense oligodeoxy-nucleotides into coronary endothelial cells by ultrasound. Biochem Biophys Res Commun 2002;298:587-590.
11. Tachibana K, Feril LB Jr, Ikeda-Dantsuji Y. Sonodynamic therapy. Ultrasonics 2008;48: 253-259.
12. Young SR, Dyson M. Effect of therapeutic ultrasound on the healing of full-thickness excised skin lesions. Ultrasonics 1990;28:175-180.
13. Takanobu Imada T, Tatsumi T, Mori Y, Nishiue T, Yoshida M, Masaki H et al. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbub-bles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol 2005;25:2128-2134.
14. Zen K, Okigaki M, Hosokawa Y, Adachi Y, Nozawa Y, Takamiya M et al. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol 2006;40:799-809.
15. Ikeda K, Takayama T, Suzuki N, Shimada K, Otsuka K, Ito K. Effects of low-intensity pulsed ultrasound on the differentiation of C2C12 cells. Life Sci 2006;79:1936-1943.
16. Pilla AA, Mont MA, Nasser PR, Khan SA, Figueiredo M, Kaufman JJ et al. Non-invasive low-intensity pulsed ultrasound accelerates bone healing in the rabbit. J Orthop Trauma 1990;4:246-253.
17. Takeuchi R, Ryo A, Komitsu N, Mikuni-Takagaki Y, Fukui A, Takagi Y et al. Low-intensity pulsed ultrasound activates the phosphatidylinositol 3 kinase/Akt pathway and stimulates the growth of chondrocytes in three-dimensional cultures: a basic science study. Arthritis Res Ther 2008;10:R77.
18. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001;108:391-397.
19. Yamaguchi K, Feril LB Jr, Tachibana K, Takahashi A, Matsuo M, Endo H et al. Ultrasound-mediated interferon b gene transfection inhibits growth of malignant melanoma. Biochem Biophys Res Commun 2011;411:137-142.
20. Hayashi S, Yamamoto M, Tachibana K, Ueno Y, Bu G, Fukushima T. Mechanism of photofrin-enhanced ultrasound-induced human glioma cell death. Anticancer Res 2009;29:897-905.
21. Katsuki Y, Sasaki K, Toyama Y, Ohtsuka M, Koiwaya H, Nakayoshi T et al. Early outgrowth EPCs generation is reduced in patients with Buerger's disease. Clin Res Cardiol 2011;100:21-27.
22. Koiwaya H, Sasaki K, Ueno T, Yokoyama S, Toyama Y, Ohtsuka M et al. Augmented neovascularization with magnetized endothelial progenitor cells in rats with hind-limb ischemia. J Mol Cell Cardiol 2011;51:33-40.
23. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343-353.
24. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endo-thelial progenitor cells. Arterioscler Thromb Vasc Biol 2008;28:1584-1595.
25. Sasaki K, Heeschen C, Aicher A, Ziebart T, Honold J, Urbich C et al. Ex vivo pretreat-ment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 2006;103:14537-14541.
26. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999;19:1156-1161.
27. Altland OD, Dalecki D, Suchkova VN, Francis CW. Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis. J Thromb Haemost 2004;2:637-643.
28. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-605.
29. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 1999;43: 532-541.
30. Cale JM, Bird IM. Inhibition of MEK/ERK1/2 signaling alters endothelial nitric oxide synthase activity in an agonist-dependent manner. Biochem J 2006;398:279-288.
31. Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009;10: 165-177.
32. Veikkola T, Alitalo K. Dual role of Ang2 in postnatal angiogenesis and lymphangiogen-esis. Dev Cell 2002;3:302-304.
33. Kim KL, Shin IS, Kim JM, Choi JH, Byun J, Jeon ES et al. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc Res 2006;72:394-402.
34. + progenitors. Blood 2004;104:2010-2019.
35. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-2890.
36. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005;111:1184-1191.
37. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109: 1615-1622.
38. Pipili-Synetos E, Sakkoula E, Maragoudakis ME. Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol 1993;108:855-857.
39. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94:2036-2044.
40. Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén MR, Kholová I et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angio-genesis. Circulation 2005;112:3937-3946.
41. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 2005;102:10999-11004.
42. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
43. Behm CZ, Kaufmann BA, Carr C, Lankford M, Sanders JM, Rose CE et al. Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation 2008;117:2902-2911.